Home › Compare › MCCX vs JNJ

MCCX vs JNJ: Dividend Comparison 2026

MCCX yields 16666.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCCX wins by $8601297707047409664.00M in total portfolio value
10 years
MCCX
MCCX
● Live price
16666.67%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8601297707047409664.00M
Annual income
$8,500,961,637,704,150,000,000,000.00
Full MCCX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MCCX vs JNJ

📍 MCCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMCCXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MCCX + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MCCX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCCX
Annual income on $10K today (after 15% tax)
$1,416,666.67/yr
After 10yr DRIP, annual income (after tax)
$7,225,817,392,048,527,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MCCX beats the other by $7,225,817,392,048,527,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCCX + JNJ for your $10,000?

MCCX: 50%JNJ: 50%
100% JNJ50/50100% MCCX
Portfolio after 10yr
$4300648853523704832.00M
Annual income
$4,250,480,818,852,075,000,000,000.00/yr
Blended yield
98.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MCCX
No analyst data
Altman Z
-228.4
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCCX buys
0
JNJ buys
0
No recent congressional trades found for MCCX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMCCXJNJ
Forward yield16666.67% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$8601297707047409664.00M ✓$20.0K
Annual income after 10y$8,500,961,637,704,150,000,000,000.00 ✓$827.78
Total dividends collected$8594666089931243520.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MCCX vs JNJ ($10,000, DRIP)

YearMCCX PortfolioMCCX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,677,367$1,666,666.67$10,676$355.77+$1.67M → MCCX
2$263,066,849$261,272,066.46$11,407$389.39+$263.06M → MCCX
3$38,576,943,838$38,295,462,310.00$12,198$426.53+$38576.93M → MCCX
4$5,289,656,888,585$5,248,379,558,677.81$13,056$467.62+$5289656.88M → MCCX
5$678,235,585,150,030$672,575,652,279,244.40$13,987$513.12+$678235585.14M → MCCX
6$81,321,145,183,775,540$80,595,433,107,665,010.00$14,998$563.56+$81321145183.76M → MCCX
7$9,118,299,079,523,715,000$9,031,285,454,177,076,000.00$16,098$619.52+$9118299079523.70M → MCCX
8$956,159,646,381,740,000,000$946,403,066,366,649,700,000.00$17,295$681.69+$956159646381740.00M → MCCX
9$93,772,027,423,605,150,000,000$92,748,936,601,976,690,000,000.00$18,599$750.82+$93772027423605152.00M → MCCX
10$8,601,297,707,047,409,000,000,000$8,500,961,637,704,150,000,000,000.00$20,022$827.78+$8601297707047409664.00M → MCCX

MCCX vs JNJ: Complete Analysis 2026

MCCX — Stock

MCX Technologies Corporation focuses on delivering digital transformation solutions to customer-centric organizations through integrated marketing, data science, and commerce in the United States. It offers professional and related consulting services, including brand strategy, pricing science, data science, digital transformation, customer experience management consulting, implementation, and go-to-market execution in support of these strategies. The company was formerly known as McorpCX, Inc. and changed its name to MCX Technologies Corporation in August 2020. MCX Technologies Corporation was incorporated in 2001 and is headquartered in Boise, Idaho.

Full MCCX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MCCX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCCX vs SCHDMCCX vs JEPIMCCX vs OMCCX vs KOMCCX vs MAINMCCX vs ABBVMCCX vs MRKMCCX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.